Guidance for Newly Released COVID-19 Coding

Diagnosing COVID-19: Effective April 1, 2020

  • U07.1 COVID-19 with laboratory confirmation
  • U07.2 COVID-19 without laboratory confirmation

Prior to April 1, 2020, the following ICD-10 diagnosis code may be used

  • B34.2 Coronavirus, unspecified

Testing for COVID-19

New HCPC codes for billing Medicare COVID-19 testing: Effective 4/1/2020

  • U0001Centers for Disease Control and Prevention (CDC) 2019 Novel Coronavirus Real Time RT-PCR Diagnostic
  • U0002 – 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets)

CPT Code for billing other payors: posted 3/13/2020 – Effective immediately

  • 87635Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique
    • Download the CPT Assistant Guide Fact Sheet (PDF) for coding guidance for the SARS-CoV-2 (COVID-19) test in relation to the use of the new CPT code. The fact sheet includes:
      • Code, descriptor and purpose
      • A clinical example
      • Description of the procedure
      • FAQs

Treating COVID-19

New injection HCPC codes for treating COVID-19 – Effective 4/1/2020

  • C9053 – Injection, crizanlizumab-tmca, 1mg
  • C9056 – Injection, givosiran, 0.5 mg
  • C9057 – Injection, cetirizine HCI, 1mg
  • C9058 – Injection, pegfilgrastim-bmez, biosimilar, (Ziextenzo) 0.5 mg